Showing results (221-230 of 384) with videos related to
Sort By:
Pageof 39
The American Journal of Physiology|October 2, 1998
Physiological changes in blood glucose affect appetite and pyloric motility during intraduodenal lipid infusionJ M Andrews, C K Rayner, S Doran, et al.Journal of Bioluminescence and Chemiluminescence|September 1, 1995
Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniquesJ Sunderland, N Brenwald, E Smith, et al.The European Respiratory Journal|September 1, 1990
Azithromycin concentrations at the sites of pulmonary infectionD R Baldwin, R Wise, J M Andrews, et al.The Journal of Antimicrobial Chemotherapy|September 1, 1989
The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacinK Nye, Y G Shi, J M Andrews, et al.Antimicrobial Agents and Chemotherapy|October 1, 1988
Pharmacokinetics and tissue penetration of orally administered lomefloxacinJ W Stone, J M Andrews, J P Ashby, et al.The Journal of Hospital Infection|March 1, 1986
Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetrationR Wise, I A Donovan, C A McNulty, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1986
The pharmacokinetics and tissue penetration of imipenemR Wise, I A Donovan, M R Lockley, et al.British Journal of Plastic Surgery|July 1, 1990
Abdominoplasty: modified plicationA Marques, E Brenda, M A Ishizuka, et al.The Journal of Antimicrobial Chemotherapy|August 1, 1991
In-vitro activity and beta-lactamase stability of SR 44337, a new long acting cephalosporinM A Cooper, J M Andrews, D R Baldwin, et al.The Journal of Antimicrobial Chemotherapy|September 1, 1991
In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibioticsM A Cooper, D Baldwin, R S Matthews, et al.Pageof 39